L’attività scientifica promossa da Fondazione Arianna ha portato alla pubblicazione dei lavori su importanti riviste internazionali.
Inoltre, numerosi contributi sui dati analizzati sono stati selezionati come poster o come comunicazioni orali ai più importanti congressi nazionali e internazionali sull’anticoagulazione.

DOWNLOAD HERE OUR PUBLICATIONS

START-Register. The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation.
Antonucci E, Poli D, Tosetto A, Pengo V, Tripodi A, Magrini N, Marongiu F, Palareti G.
PLosOne 2015

Vitamin K Antagonist Therapy: Changes in the Treated Populations and in Management Results in Italian Anticoagulation Clinics Compared with those recorded 20 years ago.
Palareti G, Antonucci E, Migliaccio L, Erba N, Marongiu F, Pengo V, Poli D, Testa S, Tosetto A, Tripodi A, Moia M; on behalf of the centres participating in the FCSA-START-Register (The ISCOAT 2016 study)
Intern and Emerg Med, 2017

 

Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome.
Patti G, et al. Calabrò P, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Ricottini E, Marcucci R.
PLoS One. 2017

PUBLISHED ARTICLES

  • Palareti G, Antonucci E, Ageno W, Mastroiacovo D, Poli D, Tosetto A. The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: reply. J Thromb Haemost, 2018
  • Palareti G Antonucci E, Mastroiacovo D, Ageno W, Pengo V, Poli D, Testa S, Tosetto A, Prandoni P. ACCP score to assess the risk of bleeding during anticoagulation: application to real-life data from the START2-REGISTRY. J Thromb Haemost, 2018
  • Poli D, Antonucci E, Pengo V, Grifoni E, Maggini M, Testa S, Lodigiani C, Insana A, Marongiu F, Paparo C, Bucherini E, Pignatelli P, Palareti G, on  the behalf of the Italian Federation of Anticoagulation Clinics. High risk for reoperation among patients with bioprosthetic heart valves and indication for long-term anticoagulation. Open Heart, 2018
  • Patti G, Ricottini E, Nenna A, CavallariI, Antonucci E, Calabrò P, Cirilo P, Gresele P,MD, Palareti G, Pengo V, Pignatelli P, Bisignagni A, Marcucci R. Differential impact of chronic renal failure on ischemic and bleeding events at one year in patients with acute coronary syndrome: insights from the multicenter START ANTIPLATELET Registry. American Journal of Cardiology, 2018
  • Cirillo P, Di Serafino L, Patti G, Antonucci E, Calabrò P,  Paolo Gresele P, Palareti G, Pengo V, Pignatelli P, Marcucci R. Gender-related differences on the choice of antiplatelet therapy and its impact on one-year clinical outcome in patients presenting with Acute Coronary Syndrome: Insights from the START Antiplatelet Registry. Angiology, 2018
  • Testa S, Ageno W, Antonucci E, Morandini R, Beyer-Westendorf J, Paciaroni M, Righini M, Sivera P, Verhamme P, Pengo V, Poli D, Palareti G. Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Events Registry. Intern Emerg Med 2018
  • Poli D, Antonucci E, Pengo V, Migliaccio L, Testa S, Lodigiani L, Coffetti N, Facchinetti R, Serricchio G, Falco P, Mangione C, Masottini S, Ruocco L, De Caterina R, Palareti G coordinator of START Registry, on  the behalf of the Italian Federation of Anticoagulation Clinics. Mechanical Prosthetic Heart Valves: quality of anticoagulation and thromboembolic risk.  The observational  multicentre PLECTRUM Study. Internat J Cardiol 2018
  • Testa S, Ageno W, Antonucci E, Morandini R,Beyer-Westendorf J, Paciaroni M, Righini M, Sivera P, Verhamme P, Pengo V, Poli D, Palareti G. Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Events Registry. Intern Emerg Med 2018
  • Poli D, Antonucci E, Pengo V, Migliaccio L, Testa S, Lodigiani L, Coffetti N,  Facchinetti R, Serricchio G, Falco P, Mangione C, Masottini S, Ruocco L, De Caterina R, Palareti G coordinator of START Registry, on  the behalf of the Italian Federation of Anticoagulation Clinics. Mechanical Prosthetic Heart Valves: quality of anticoagulation and thromboembolic risk.  The observational  multicentre PLECTRUM Study. Internat J Cardiol 2018
  • Testa S, Paoletti O, Cristina Legnani, Dellanoce C, Antonucci E, Cosmi B, Pengo V, Poli D,Morandi R, Testa R, Tripodi A and Gualtiero Palareti Palareti G, Coordinator of START Registry. Low drug levels and thrombotic complications in high risk atrial fibrillation patients treated with direct oral anticoagulants. J Thromb Haemost 2018
  • Calabrò P, Gragnano F, Di Maio M, Patti G, Antonucci E, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Pennacchi M, Granatelli A, De Servi S, De Luca L, Marcucci R. Epidemiology and management of patients with acute coronary syndromes in real-world practice: evolving trends from the EYESHOT study to the START-ANTIPLATELET registry. Angiology 2018
  • Cini M, Legnani C, Cosmi B, Testa S, Dellanoce C, Paoletti O, Marcucci R, Poli D, Paniccia R, Pengo V, Tripodi A, Palareti G; START-Laboratory Register.  Comparison of five specific assays for determination of dabigatran plasma concentrations in patients enrolled in the START-Laboratory Register. International Journal of Laboratory Hematology, 2018
  • Tosetto A, Testa S, Martinelli I, Poli D, Cosmi B, Lodigiani C, Ageno W, De Stefano V, Falanga A, Nichele I, Paoletti O, Bucciarelli P, Antonucci E, Legnani C, Banfi E, Dentali F, Bartolomei F, Barcella L, Palareti G. External validation of the DASH prediction rule: a retrospective cohort study. J Thromb Haemost. 2017
  • Patti G, et al. Calabrò P, Cirillo P, Gresele P, Palareti G, Pengo V, Pignatelli P, Ricottini E, Marcucci R. Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome. PLoS One. 2017
  • Gentian D, Zoppellaro G, Padayattil Jose S, Antonucci E, Marongiu F, Poli D, Testa S, Tripodi A, Palareti G, Pengo V. Warfarin prescription in patients with non-valvular atrial fibrillation and one non-gender related risk factor (CHA2DS2VASc 1 or 2): a treatment dilemma. Cardiovascular Therapeutics, 2017
  • Palareti G, Antonucci E, Migliaccio L, Erba N, Marongiu F, Pengo V, Poli D, Testa S, Tosetto A, Tripodi A, Moia M; on behalf of the centres participating in the FCSA-START-Register (The ISCOAT 2016 study). Vitamin K Antagonist Therapy: Changes in the Treated Populations and in Management Results in Italian Anticoagulation Clinics Compared with those recorded 20 years ago. Intern and Emerg Med, 2017
  • Poli D, Antonucci E, Pengo V, Testa S, Palareti G. Comparison of HAS-BLED and HAS-BED Versus CHADS2 and CHA2DS2VASC Stroke and Bleeding Scores in patients with atrial fibrillation. Am J Cardiol 2017
  • Testa S, Tripodi A, Legnani C, et al; START-Laboratory Register. Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: Results observed in four anticoagulation clinics.  Thromb  Res 2016
  • Testa S, Legnani C, Tripodi A, et al. Poor comparability of coagulation screening test with specific measurement in patients on direct oral anticoagulants: results from a multicenter/multiplatform study. J Thromb Haemost 2016
  • Palareti G, Antonucci E, Lip GY, et al . The SAME-TT2R2 score predicts the quality of anticoagulation control in patients with acute VTE. A real-life inception cohort study. Thromb Haemost. 2016
  • Antonucci E, Poli D, Tosetto A, Pengo V, Tripodi A, Magrini N, Marongiu F, Palareti G; START-Register. The Italian START-Register on Anticoagulation with Focus on Atrial Fibrillation. PLosOne 2015

 SUBMITTED ARTICLES

  • Marcucci R, Gori AM, Patti G, Cirillo P, Calabrò P, Pengo V, Gresele P, Pignatelli P, Antonucci E, Valente S, Palareti G for Start-antiplatelet Investigators. Antiplatelet treatment in acute coronary syndrome patients: real-world data from the START Antiplatelet Italian Registry
  • Testa S, Legnani C, Antonucci A, Paoletti O, Dellanoce C, Cosmi B, Pengo V, Poli D, Morandini R, Testa R, Tripodi A, Palareti G Drug Levels And Bleeding Complications In Atrial Fibrillation Patients Treated With Direct Oral Anticoagulants.
  • Poli D, Antonucci E , Ageno W, Bertù L, Migliaccio L, Martinese L, Pilato G, Testa S, Palareti G. Oral anticoagulation with VKAs or DOACs in very elderly patients with atrial fibrillation. results from the prospective multicenter START2 Register study.

TRIP GROUP ARTICLES 

  • Tosetto A, Testa S, Martinelli I, Poli D, Cosmi B, Lodigiani C, Ageno W, De Stefano V, Falanga A, Nichele I, Paoletti O, Bucciarelli P, Antonucci E, Legnani C, Banfi E, Dentali F, Bartolomei F, Barcella L, Palareti G. External validation of the DASH prediction rule: a retrospective cohort study. J Thromb Haemost. 2017

Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni

Questo sito utilizza i cookie per fornire la migliore esperienza di navigazione possibile. Continuando a utilizzare questo sito senza modificare le impostazioni dei cookie o cliccando su "Accetta" permetti il loro utilizzo.

Chiudi